The balance sheet remains conservatively leveraged with a D/E ratio of 0.05 and cash of $3.1B, while equity has grown to $8.6B from $5.3B over ten quarters, driven by retained earnings of $4.7B.
| Total Current Assets | 6.34B | 6.24B | 4.83B | 4.2B | 3.54B | 3.09B |
| Cash & Short-Term Investments | 3.89B | 3.6B | 2.83B | 2.92B | 2.21B | 1.64B |
| Cash Only | 3.06B | 2.75B | 2.08B | 1.92B | 1.55B | 1B |
| Short-Term Investments | 830M | 850M | 740M | 1B | 661M | 631M |
| Accounts Receivable | 2B | 2.47B | 1.9B | 1.13B | 1.17B | 1.29B |
| Days Sales Outstanding | 149.6 | 182.95 | 172.89 | 127.46 | 158.73 | 174.2 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - |
| Other Current Assets | 451M | 0 | 0 | 145M | 157M | 167M |
| Total Non-Current Assets | 4.86B | 4.47B | 4.1B | 3.73B | 3.33B | 3.42B |
| Property, Plant & Equipment | 1.39B | 1.15B | 714M | 420M | 391M | 417M |
| Fixed Asset Turnover | 4.35x | 4.27x | 5.61x | 7.70x | 6.85x | 6.48x |
| Goodwill | 1.62B | 1.62B | 1.62B | 1.63B | 1.62B | 1.64B |
| Intangible Assets | 217M | 230M | 151M | 152M | 138M | 205M |
| Long-Term Investments | 2.52B | 387M | 962.8M | 773.4M | 753.9M | 765M |
| Other Non-Current Assets | 612M | 701M | 253.2M | 477.6M | 287.1M | 260M |
| Total Assets | 11.2B | 10.7B | 8.93B | 7.93B | 6.87B | 6.51B |
| Asset Turnover | 0.49x | 0.46x | 0.45x | 0.41x | 0.39x | 0.42x |
| Asset Growth % | 78.86% | 19.83% | 12.68% | 15.45% | 5.47% | - |
| Total Current Liabilities | 1.21B | 1.04B | 929M | 1.5B | 1.36B | 1.4B |
| Accounts Payable | 0 | 80M | 63M | 26M | 65M | 57M |
| Days Payables Outstanding | 85.55 | 78.92 | 111.63 | 40.56 | 121.67 | 94.57 |
| Short-Term Debt | 0 | 0 | 40M | 32M | 26M | 31M |
| Deferred Revenue (Current) | 1.13B | 294M | 209M | 198M | 293M | 334M |
| Other Current Liabilities | 852M | 225M | 153M | 130M | 228M | 202M |
| Current Ratio | 5.25x | 6.00x | 5.20x | 2.79x | 2.60x | 2.22x |
| Quick Ratio | 5.25x | 6.00x | 5.20x | 2.79x | 2.60x | 2.22x |
| Cash Conversion Cycle | 64.05 | - | - | - | - | - |
| Total Non-Current Liabilities | 1.36B | 1.38B | 1.16B | 1.13B | 1.45B | 1.57B |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 1.59B | 393M | 316M | 194M | 193M | 230M |
| Deferred Tax Liabilities | 95M | 39M | 42.6M | 150.5M | 262M | 279M |
| Other Non-Current Liabilities | 174M | 193M | 103.4M | 65.5M | 190M | 266M |
| Total Liabilities | 2.57B | 2.42B | 2.09B | 2.63B | 2.81B | 2.96B |
| Total Debt | 464M | 457M | 356M | 226M | 219M | 261M |
| Net Debt | -2.59B | -2.29B | -1.73B | -1.7B | -1.33B | -743M |
| Debt / Equity | 0.05x | 0.06x | 0.05x | 0.04x | 0.05x | 0.07x |
| Debt / EBITDA | 0.40x | 0.39x | 0.35x | 0.87x | 0.26x | 0.30x |
| Net Debt / EBITDA | -2.24x | -1.98x | -1.71x | -6.50x | -1.57x | -0.87x |
| Interest Coverage | - | - | - | - | - | - |
| Total Equity | 8.63B | 8.29B | 6.84B | 5.29B | 4.05B | 3.55B |
| Equity Growth % | 89.01% | 21.16% | 29.16% | 30.71% | 14.18% | - |
| Book Value per Share | 8.01 | 7.76 | 6.43 | 5.07 | 3.95 | 3.46 |
| Total Shareholders' Equity | 8.63B | 8.29B | 6.84B | 5.29B | 4.05B | 3.55B |
| Common Stock | 2M | 2M | 2M | 2M | 2M | 2M |
| Retained Earnings | 4.72B | 4.45B | 3.54B | 2.75B | 2.46B | 1.93B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 373M | 370M | 372M | 371M | 376M | 399M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
SBC dilution and R&D intensity
ARM's equity expanded from $5.3B to $8.6B over ten quarters, with retained earnings nearly doubling to $4.7B, as per the latest balance sheet, indicating sustained profitability and internal capital generation.
The sequential growth in total assets from $7.9B to $11.2B, driven primarily by retained earnings and cash accumulation, suggests a structurally strengthening balance sheet. The consistent rise in equity, even as liabilities remained relatively flat, points to a business that is increasingly self-funding its growth. This trajectory implies that ARM's asset base is expanding faster than its obligations, a sign of improving financial flexibility.
Total debt rose to $464M in 2027Q1 from $226M in 2024Q4, yet D/E remains a low 0.05, as reported in financial statements, suggesting debt is a minor component of the capital structure.
The near-doubling of total debt over the period, with a spike to $858M in 2026Q3, appears to be a temporary working capital or financing event rather than a strategic shift toward leverage. With D/E consistently below 0.11 and cash balances exceeding debt, ARM's leverage is negligible, implying minimal refinancing risk. The low debt levels relative to equity and cash suggest that ARM's operations are largely equity-funded, which may indicate a conservative capital structure that prioritizes financial stability.
PPE net grew from $420M to $1.4B over ten quarters, while goodwill remained flat at $1.6B, as per the balance sheet, indicating increased investment in physical assets despite an asset-light core.
The significant expansion in PPE, more than tripling, suggests ARM is investing in infrastructure, possibly for data centers or design tools, which may signal a shift toward a more capital-intensive model. However, goodwill staying constant at $1.6B implies no major acquisitions, and the overall asset base remains dominated by cash and intangibles, consistent with a licensing business. The rising PPE could be a response to growth in royalty processing or AI-related demand, but it also introduces depreciation costs that could pressure margins.
Retained earnings climbed to $4.7B in 2027Q1 from $2.8B in 2024Q4, as per the balance sheet, while share repurchases occurred, indicating equity growth is primarily from operations.
The doubling of retained earnings over the period, despite buybacks, suggests that ARM is generating substantial profits that are being reinvested in the business. The absence of a large common stock issuance implies that equity expansion is not dilution-driven, which is positive for existing shareholders. However, the prior income statement analysis highlighted significant SBC, which could dilute equity over time, but the balance sheet data shows a net increase in equity, suggesting that retained earnings are outpacing dilution.
Cash rose to $3.1B in 2027Q1 from $1.9B in 2024Q4, and the current ratio improved to 5.25 from 2.79, as per the latest balance sheet, indicating a robust liquidity position.
The substantial increase in cash and current ratio suggests ARM has a strong buffer against operational shocks and can fund its R&D and capex without external financing. The current ratio of 5.25 is well above the peer average, indicating superior short-term solvency. This liquidity, combined with low debt, implies that ARM is well-positioned to weather downturns or seize strategic opportunities, though the high cash balance may also indicate underutilized capital.
Deferred revenue remained stable around $1.0B over the last five quarters, as per the balance sheet, suggesting consistent advance payments from customers and predictable future revenue.
The stability of deferred revenue, hovering near $1B, indicates that ARM's licensing model generates recurring upfront payments, providing visibility into near-term revenue. The slight increase to $939M in 2027Q1 from $915M in 2024Q4 is modest but suggests steady demand. This metric, combined with the accelerating revenue growth, implies that ARM's forward revenue pipeline is healthy, though the lack of a significant build-up may indicate that growth is more dependent on new deals rather than existing contracts.
Stock-based compensation averaged $220M per quarter over the last ten quarters, as per the cash flow statement, which may inflate cash balances and understate true equity cost.
While the balance sheet shows robust equity growth and cash accumulation, the heavy use of SBC, which is a non-cash expense, means that reported equity may be overstated relative to actual shareholder value. The cash flow statement indicates that SBC adds back to operating cash flow, boosting cash balances, but this does not represent true cash generation. Investors should monitor the dilutive impact of SBC on future EPS and consider adjusting equity metrics to reflect the economic cost of employee compensation.
Quick answers to the most common questions about buying ARM stock.
As of 2026, Arm Holdings plc American Depositary Shares (ARM) had total assets of $10.70B including $6.24B in current assets.
Arm Holdings plc American Depositary Shares (ARM) carries total debt of $457.0M, offset by $3.60B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Arm Holdings plc American Depositary Shares (ARM) has total shareholders' equity (book value) of $8.29B ($7.76 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Arm Holdings plc American Depositary Shares (ARM) reported a current ratio of 6.00x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.